Drug results: 1
| bosentan | a specific and competitive antagonist at endothelin receptor types ETA and ETB, has a slightly higher affinity for ETA receptors than for ETB receptors, indicated for the treatment of pulmonary arterial hypertension |
|








Citing DrugCentral © 2025.
License